Table 3. Colposcopic findings.

(number of AEs and number of participants experiencing AE denoted by [ ])

	Block I 5 × 108 cfu/dose)		Block II (1 × 109 cfu/dose)		Block III (2 × 109 cfu/dose)		Total
Colposcopic finding	LACTIN-V	Placebo	LACTIN-V	Placebo	LACTIN-V	Placebo	LACTIN-V	Placebo
Erythema	-	-	-	1	1	-	1	1
Petechiae	-	-	1	-	-	-	1	-
Edema	-	1	-	-	-	-	-	1
Abrasion *	-	-	1	-	-	-	1	-
Laceration *	-	1	-	-	-	-	-	1
Other	-	-	-	1	-	-	-	1
Total number of findings [women with at least one finding] †	-	2 [1]	2 [2]	2 [1]	1 [1]	-	3 [3]	4 [2]

^*Findings with disrupted epithelium, all of which were considered superficial.

^†The total number of women may not equal the column sum because a given woman may have more than one type of finding.

Only those Colposcopic findings which were discovered after (but not at) visit 1 (enrollment visit) were included in Table 1 as earlier findings could not possibly have been related to the study product.